FIELD: medicine.
SUBSTANCE: invention refers to medicine, specifically to pharmaceutical compositions possessing prolonged antiarrhythmic actions and applicable to correct the cardiac arrhythmia, including that of the ischemic origin. What is presented is a pharmaceutical composition with the prolonged antiarrhythmic acitivity containing bis[2-(diethylamino)]-N-(2,6-dimethylphenyl)acetamide L-glutaminate, L-glutamic acid, 2-aminoethane sulpho-acid and excipients.
EFFECT: prolonged antiarrhythmic action and stability of the dosage form (tablets, capsules for oral application or solution for injections).
3 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 2-(DIETHYLAMINO)-N-(2,6-DIMETHYLPHENYL)ACETAMIDE L-GLUTAMATE, HAVING PROLONGED ANTIARRHYTHMIC ACTIVITY, PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2697717C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTIARRHYTHMIC ACTIVITY OF VARIOUS ETIOLOGIES | 2021 |
|
RU2783944C1 |
| AGENT POSSESSING ANTIARRHYTHMIC ACTION | 2019 |
|
RU2700263C1 |
| METHOD OF PRODUCING A 2,6-DIMETHYLPHENYLACETAMIDE DERIVATIVE HAVING CEREBROPROTECTIVE ACTIVITY | 2018 |
|
RU2690506C1 |
| COMPOUND OF NIBENTANE AND AMINO ACID POSSESSING ANTIARHYTHMIC ACTIVITY AND METHOD FOR PRODUCING IT | 2014 |
|
RU2572710C1 |
| APPLICATION OF LIDOCAINE DERIVATIVE WITH LOCAL ANESTHETIC ACTIVITY, FOR TERMINAL ANESTHESIA | 2016 |
|
RU2628811C1 |
| METHOD OF INCREASING THE STABILITY OF INJECTION PHARMACEUTICAL COMPOSITION | 2017 |
|
RU2666607C1 |
| ANTI-ISCHEMIC REMEDY POSSESSING ANTI-ARRHYTHMIC AND ANTI-ATHEROGENIC ACTIVITY AND METHOD FOR APPLYING THE MEANS | 2004 |
|
RU2259822C1 |
| VAGINAL ANTIARRHYTHMIC AGENTS FOR PELVIC PAIN TREATMENT | 2002 |
|
RU2345758C2 |
| AGENT POSSESSING ANTIARRHYTHMIC, ANTIFIBRILLATORY, ANTI-ISCHEMIC ACTION, AND BASED PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2477130C1 |
